Sign up to save your podcasts
Or
Share Behind the landmark WHO decision on essential medicines for MS
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Behind the landmark WHO decision on essential medicines for MS
Multiple sclerosis (MS) treatments have been successfully added onto the World Health Organisation's Essential Medicines List (EML) in July 2023. Nick Rijke of the MS International Federation and Deanna Saylor of Johns Hopkins Hospital discuss the impact of this milestone and the next steps for clinicians, researchers, patients, and the MS community at large.
View all episodes
By The European Committee for Treatment and Research in Multiple Sclerosis
4.5
22 ratings
Multiple sclerosis (MS) treatments have been successfully added onto the World Health Organisation's Essential Medicines List (EML) in July 2023. Nick Rijke of the MS International Federation and Deanna Saylor of Johns Hopkins Hospital discuss the impact of this milestone and the next steps for clinicians, researchers, patients, and the MS community at large.
More shows like The ECTRIMS Podcast
View all
Neurology® Podcast
280 Listeners
StarTalk Radio
14,007 Listeners
Freakonomics Radio
32,197 Listeners
Practical Neurology Podcast
34 Listeners
Pivot
8,764 Listeners
The Daily
111,673 Listeners
Up First from NPR
56,111 Listeners
RealTalk MS
139 Listeners
Feel Better, Live More with Dr Rangan Chatterjee
4,131 Listeners
Neurology Today in 5
21 Listeners
The Lancet Neurology in conversation with
3 Listeners
The MSing Link
111 Listeners
ZOE Science & Nutrition
1,922 Listeners
Continuum Audio
74 Listeners
MeSsy with Christina Applegate & Jamie Lynn Sigler
3,426 Listeners